Literature DB >> 20567629

Re-irradiation of metastatic disease in the neck from xeroderma pigmentosum.

C C Wei1, N J Sanfilippo, D Myssiorek.   

Abstract

BACKGROUND: Xeroderma pigmentosum, an autosomal recessive disease that occurs with a frequency of 1:250,000, is caused by a genetic defect in nucleotide excision repair enzymes. Mutation of these enzymes leads to the development of multiple basal cell and squamous cell carcinomas.
OBJECTIVES: We present a case of xeroderma pigmentosum in a patient with cervical and intraparotid metastatic disease from recurrent cutaneous squamous cell carcinomas of the face and scalp, treated with neck dissection and re-irradiation. With the illustrative case report, we include a literature review of diagnosis, prognostic factors, and treatment, with emphasis on surgical and radiation treatment of cervical metastatic disease from recurrent skin carcinomas. CASE
PRESENTATION: A xeroderma pigmentosum patient presented to our clinic with a 2-cm right submental and 1-cm right infra-auricular mass after resection of multiple squamous cell carcinomas of the scalp and face, and external-beam radiation therapy to the right face and neck. Fine-needle aspiration biopsy of the submental mass revealed poorly differentiated squamous cell carcinoma. The patient was brought to the operating room for a right modified radical neck dissection and excision of the right submental and intraparotid mass. Surgical pathology revealed 3 level ia and supraclavicular lymph nodes that were positive for metastatic squamous cell carcinoma. Re-irradiation to the entire right hemi-neck and left submandibular nodal region was performed using opposed oblique portals for the upper neck and a low anterior en face hemi-neck portal. The left parotid region was also included in the re-irradiation volume. Treatment was completed without delayed complications or recurrences to date.
CONCLUSIONS: To our knowledge, this is the first case report in the literature of a patient with xeroderma pigmentosum who subsequently developed metastatic disease from recurrent cutaneous squamous cell carcinoma. Because of the rarity of xeroderma pigmentosum, this case report is also the first to describe re-irradiation to treat cervical and intraparotid metastatic disease in a xeroderma pigmentosum patient.

Entities:  

Keywords:  Xeroderma pigmentosum; head-and-neck cancer; radiation; re-irradiation

Year:  2010        PMID: 20567629      PMCID: PMC2880910          DOI: 10.3747/co.v17i3.479

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  7 in total

Review 1.  Re-irradiation in the management of isolated neck recurrences: current status and recommendations.

Authors:  Supriya Chopra; Tejpal Gupta; Jai Prakash Agarwal; Ashwini Budrukkar; Sarbani Ghosh-Laskar; Ketayun Dinshaw
Journal:  Radiother Oncol       Date:  2006-09-12       Impact factor: 6.280

Review 2.  Four radiation hypersensitivity cases and their implications for clinical radiotherapy.

Authors:  P B Rogers; P N Plowman; S J Harris; C F Arlett
Journal:  Radiother Oncol       Date:  2000-11       Impact factor: 6.280

3.  Xeroderma pigmentosum: spinal cord astrocytoma with 9-year survival after radiation and isotretinoin therapy.

Authors:  J J DiGiovanna; N Patronas; D Katz; D Abangan; K H Kraemer
Journal:  J Cutan Med Surg       Date:  1998-01       Impact factor: 2.092

Review 4.  Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases.

Authors:  Michael I Koukourakis; Efstratios Maltezos
Journal:  Anticancer Drugs       Date:  2006-02       Impact factor: 2.248

5.  Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum.

Authors:  C F Arlett; P N Plowman; P B Rogers; C N Parris; F Abbaszadeh; M H L Green; T J McMillan; C Bush; N Foray; A R Lehmann
Journal:  Br J Radiol       Date:  2006-06       Impact factor: 3.039

Review 6.  Xeroderma pigmentosum and skin cancer.

Authors:  Leela Daya-Grosjean
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

7.  Xeroderma pigmentosum: neck lymph node metastasis of a squamous cell carcinoma of the skin treated with cetuximab.

Authors:  Jordi Rubió Casadevall; Begoña Graña-Suárez; Xavier Hernandez-Yagüe; Jordi Vayreda Ribera; Oscar Huc Grasa; Joan Brunet Vidal
Journal:  Eur J Dermatol       Date:  2008-12-23       Impact factor: 3.328

  7 in total
  3 in total

Review 1.  Therapeutics of xeroderma pigmentosum: A PRISMA-compliant systematic review.

Authors:  Fernando Antônio Gomes de Andrade; Claudio Eduardo de Oliveira Cavalcanti; Felipe Contoli Isoldi; Lydia Masako Ferreira
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Mar-Apr       Impact factor: 2.545

2.  Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice.

Authors:  Robert N Rainey; Sum-Yan Ng; Juan Llamas; Gijsbertus T J van der Horst; Neil Segil
Journal:  J Neurosci       Date:  2016-04-27       Impact factor: 6.167

3.  Unresectable and chemoresistant conjunctival squamous cell carcinoma on xeroderma pigmentosum treated by salvage radiation therapy: A case report and a review of the literature.

Authors:  Mané Maimouna; Benkhaled Sofian; Guèye Latifatou; Eyenga Joséphine Frédérique Mendouga; Gaye Papa Macoumba; Dieng Mamadou Moustapha; Van Gestel Dirk
Journal:  Clin Case Rep       Date:  2022-09-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.